Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel
- PMID: 17638515
- DOI: 10.2217/14622416.8.7.803
Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel
Abstract
Paclitaxel is widely used in many cancers including ovarian, breast, lung, head and neck and primary unknown. Paclitaxel is extensively metabolized by cytochrome P450s and excreted in bile. The cytochromes involved include 2C8 and 3A4. This is a review of the pharmacokinetics, pharmacodynamics, drug interactions, metabolism and pharmacogenomics of paclitaxel.
Similar articles
-
Pharmacogenetics of paclitaxel metabolism.Crit Rev Oncol Hematol. 2007 Mar;61(3):222-9. doi: 10.1016/j.critrevonc.2006.09.006. Epub 2006 Nov 7. Crit Rev Oncol Hematol. 2007. PMID: 17092739 Review.
-
Pharmacogenomics of importance for paclitaxel chemotherapy.Pharmacogenomics. 2008 Jun;9(6):671-4. doi: 10.2217/14622416.9.6.671. Pharmacogenomics. 2008. PMID: 18518845
-
[Paclitaxel].Rev Med Univ Navarra. 1996 Jul-Sep;40(3):43-51. Rev Med Univ Navarra. 1996. PMID: 9499826 Review. Spanish. No abstract available.
-
Nonlinear pharmacokinetics of paclitaxel in ovarian cancer patients.Acta Pharmacol Sin. 2000 Jul;21(7):596-9. Acta Pharmacol Sin. 2000. PMID: 11360664
-
A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.Cancer Res. 1999 Mar 1;59(5):1036-40. Cancer Res. 1999. PMID: 10070960
Cited by
-
Therapeutic Applications of Solid Dispersions for Drugs and New Molecules: In Vitro and In Vivo Activities.Pharmaceutics. 2020 Sep 30;12(10):933. doi: 10.3390/pharmaceutics12100933. Pharmaceutics. 2020. PMID: 33007806 Free PMC article. Review.
-
The essential role of TTC28 in maintaining chromosomal stability via HSPA8 chaperone-mediated autophagy.Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2409447121. doi: 10.1073/pnas.2409447121. Epub 2024 Dec 4. Proc Natl Acad Sci U S A. 2024. PMID: 39630868 Free PMC article.
-
Extracellular vesicles of trypomastigotes of Trypanosoma cruzi induce changes in ubiquitin-related processes, cell-signaling pathways and apoptosis.Sci Rep. 2023 May 10;13(1):7618. doi: 10.1038/s41598-023-34820-6. Sci Rep. 2023. PMID: 37165081 Free PMC article.
-
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.Clin Cancer Res. 2022 Aug 2;28(15):3214-3224. doi: 10.1158/1078-0432.CCR-21-4363. Clin Cancer Res. 2022. PMID: 35583817 Free PMC article. Clinical Trial.
-
Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells.J Cancer Res Clin Oncol. 2014 Jun;140(6):921-35. doi: 10.1007/s00432-014-1645-z. J Cancer Res Clin Oncol. 2014. PMID: 24659394 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources